As anticipated in the title, this contribution is basically divided into two, strictly connected,
parts. The first is a personal overview of the ruthenium drug candidate NAMI‐A, almost 30 …

Interest in Ru anticancer drugs has been growing rapidly since NAMI-A ((ImH+)[RuIIICl4
(Im)(S-dmso)], where Im= imidazole and S-dmso= S-bound dimethylsulfoxide) or KP1019 …

Resistance to chemotherapy is a current clinical problem, especially in the treatment of
microbial infections and cancer. One strategy to overcome this is to make new derivatives of …

It is one of the challenging works to deal with second major cause of death due to cancer
and to reduce the mortality rate caused by this. Researchers have been finding various …

New anticancer ruthenium (II/III) complexes [RuCl2 (DMSO) 2 (Hapbim)](1) and [RuCl3
(DMSO)(Hapbim)](2)(Hapbim= 2-aminophenyl benzimidazole) have been synthesized and …

A novel straightforward method has been introduced to synthesize two new water soluble Pd
complexes,[Pd (phd)(AA)] NO 3,(phd= 1, 10-phenanthroline-5, 6-dione; 1, AA= L-isoleucine …

Ru (DMSO) 4Cl2 is a good precursor complex in synthetic inorganic chemistry and also
considered to be an efficient anti-cancer drug. Here in, we are reporting∼ 80nm nano …

With the aim of systematically studying fundamental structure–activity relationships as a
basis for the development of RuII arene complexes (arene= p‐cymene or biphenyl) bearing …

Photoactivation is a promising approach for modulating the biological activity of RuII
compounds. In this work, RuII flavonolato compounds,[Ru (η6-p-cymene)(L)(3-Hfl)] OTf (8; 3 …

The Ru (II) complex fac-[RuCl (dmso-S) 3 (dmso-O) 2][PF6](P2) was found to be an excellent
precursor for the facile preparation in high yield of half sandwich-type compounds of the …